Filing Details

Accession Number:
0001567619-18-004622
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-26 16:12:01
Reporting Period:
2018-10-24
Accepted Time:
2018-10-26 16:12:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1382911 Orexigen Therapeutics Inc. OREXQ () MA
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
899869 A Seth Klarman 10 St. James Avenue
Suite 1700
Boston MA 02116
No No Yes No
1061768 Baupost Group Llc/ma 10 St. James Avenue
Suite 1700
Boston MA 02116
No No Yes No
1738693 Baupost Group Gp, L.l.c. 10 St. James Avenue
Suite 1700
Boston MA 02116
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-10-24 28,000 $0.01 2,198,839 No 4 S Indirect See footnote 1 and 2
Common Stock Disposition 2018-10-25 652,500 $0.01 1,546,339 No 4 S Indirect See footnote 1 and 2
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote 1 and 2
No 4 S Indirect See footnote 1 and 2
Footnotes
  1. This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), Baupost Group GP, L.L.C. ("BG GP"), and Seth A. Klarman (collectively, the "Reporting Persons"). Baupost is a registered investment adviser and acts as an investment adviser to various private investment limited partnerships. BG GP, as the Manager of Baupost, and Seth A. Klarman, as the Managing Member of BG GP and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934, as amended, of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost were purchased on behalf of certain of such partnerships.
  2. (Continued from footnote 1) The Reporting Persons disclaim beneficial ownership of the securities indicated except to the extent of their pecuniary therein, and the reporting herein of such securities shall not be construed as an admission that the Reporting Persons are the beneficial owners thereof for purpose of Section 16 or for any otherpurpose.